Alzheon
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
111 Speen St Ste 306, Framingham, Massac...Phone Number
(508) 861-7709Website
www.alzheon.comRevenue
$6.3 MillionIndustry
About Alzheon
Alzheon is a clinical-stage biopharmaceutical company focused on developing innovative medicines for patients with Alzheimer's disease and other neurological disorders. The company is advancing its lead program, Valiltramiprosate (ALZ-801), which is currently in Phase 3 trials and aims to inhibit amyloid aggregation. Alzheon employs a precision medicine approach and has a discovery platform for small molecules targeting neurodegenerative conditions. Their intended clients include patients suffering from Alzheimer's disease, particularly those with specific genetic profiles.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAlzheon Org Chart
Compare Similar Companies to Alzheon
Compare insights from companies similar to Alzheon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alzheon Tech Stack
A closer look at the technologies used by Alzheon
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alzheon
Sign Up For FreeTo access detailed company insights
Alzheon is a clinical-stage biopharmaceutical company focused on developing innovative medicines for patients with Alzheimer's disease and other neurological disorders. The company is advancing its lead program, Valiltramiprosate (ALZ-801), which is currently in Phase 3 trials and aims to inhibit amyloid aggregation. Alzheon employs a precision med... Read More